… Given that these pathways promote acquired EGFR-TKI resistance 22,23 , we hypothesized
… the Wnt/β-catenin and NF-κB pathways in acquired erlotinib resistance in PC9 cells. Here, …

… nexus between Wnt/β-catenin and NF-κB pathways [42], (Table 1). … Progesterone
receptor membrane component 1 leads to erlotinib resistance, initiating crosstalk of Wnt/β-catenin …

… components of the PGRMC1 and PGRMC2 signal transduction pathways such as NF-κB
signaling and Wnt/β-catenin … to erlotinib resistance, initiating crosstalk of Wnt/beta-catenin and …

… crosstalk between the WNT/β-catenin and NF-κB pathways leading to erlotinib resistance. …
the maintenance of tumour-initiating cells (cancer stem cells) and WNT downstream targets …

… cancer cells, studies suggest more cross talk between NF-κB … C-Met and Wnt-β-catenin
signaling pathways mainly … -Ras affect resistance to treatment with gefitinib or erlotinib drugs [135]…

… and has crosstalk with other cancer promoting pathways. … However, other pathways such
as Wnt/β-catenin pathway is … For example, the transcription factors NF-κB and STAT3 promote …

… The cross-talk of the Wnt/β-catenin signaling pathway with … EGFR, leading to the activation
of the Wnt/β-catenin and NF-κB … to anticancer drugs-protein kinase inhibitors such as erlotinib…

… Wnt/β-catenin, mTORC1, STAT3, NF-κB and Notch signaling … of the estrogen and progesterone
receptors and the lack of … erlotinib potently repressed growth of erlotinib-resistant lung …

… The Wnt/β-catenin pathway is correlated with tumor cell … component 1 conferred resistance
to EGFR-targeted therapy … due to interference with cell cycle regulation and the NF-κB …

… -promoting factor increases erlotinib cytotoxicity. Based on the … mediates crosstalk of Wnt
and NF-κB to increase cancer … Progesterone receptor membrane component 1 leads to …